Adma Biologics (ADMA) closed the most recent trading day at $9.16, moving +2.35% from the previous trading session. The stock ...

If you have suffered a loss on your ADMA Biologics, Inc. ("ADMA" or the "Company") (NASDAQ:ADMA) investment, contact Lauren Molinaro of Kirby McInerney LLP by email at [email prot ...

Adma Biologics (ADMA) closed at $8.37 in the latest trading session, marking a -4.34% move from the prior day.

Year-End 2025 Cash Grew to Approximately $88 Million with an Unaudited Operating Cash Flow Estimate of $40 Million in 4Q 2025 2026 Expected to be ADMA's First Full Year of Yield-Enhanced Production, ...

These stocks are better bets to skyrocket than the much-hyped rocket stock.

The MarketWatch News Department was not involved in the creation of this content. Short seller's Characterization of ASCENIV's Competitive Position Reflects Blatant Misunderstanding of ADMA's Business ...

Key Points Interested in Vera Therapeutics, Inc.? Here are five stocks we like better. For biopharma companies, a huge amount ...

In the latest trading session, Adma Biologics (ADMA) closed at $8.69, marking a +1.4% move from the previous day. The stock's change was more than the S&P 500's daily loss of 1.44%. Elsewhere, the Dow ...

ADMA makes plasma-derived biologics to treat infectious diseases and immune deficiencies. The company reported second-quarter revenue of $60.1 million, up 77% year over year. It also trimmed its ...

CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of investors of ADMA Biologics, Inc. who were adversely affected if they purchased the Company's securities between August 9, 2024 and ...